A critical review on Glaucoma and its management in Ayurveda
International journal of Indian medicine · 2022
DOI: 10.55552/ijim.2022.3402 ↗Kurz gefasst
Fachartikel in der Zeitschrift International journal of Indian medicine, 2022. Verfasst von Niras Anjali.
Abstract (Originalsprache)
Shalakya tantra is a branch of Ashtanga Ayurveda that treats Chakshu, Nasa, Shirah, Kantha, Mukha and Karna diseases. Glaucoma is an optic nerve neurodegenerative disease which mainly affects people in their forties and fifties caused by a group of ocular conditions which lead to damage of optic nerve with loss of visual function. Glaucoma is the world's second-leading cause of irreversible blindness, and India's third-leading cause. This ailment is connected to Adhimantha in Ayurveda. Adhimantha is a Sarvagata netraroga according to Acharya Sushruta and Vagbhatta. It is identical to Glaucoma in terms of etiopathogenesis, clinical characteristics, consequences, and therapeutic concepts. Prana-Vyana vayu, and Alochaka pitta are the Doshas and Rasa-Raktha-Mamsa- are the Dushyas involved in the pathophysiology. This results in the Optic Nerve Head alterations and field abnormalities that might lead to blindness. Ayurvedic management prevents eye ageing, rejuvenates the eyes, and enhances eye function. Medicines used topically have a greater bioavailability than drugs administered orally. Ayurvedic medicines and therapies keep the body in check, illness as well as prevent blindness.
Zitieren
APA
Anjali, N. (2022). A critical review on Glaucoma and its management in Ayurveda. International journal of Indian medicine. https://doi.org/10.55552/ijim.2022.3402
Vancouver
Anjali N. A critical review on Glaucoma and its management in Ayurveda. International journal of Indian medicine. 2022. doi:10.55552/ijim.2022.3402
BibTeX
@article{Anjali2022,
author = {Anjali, Niras},
title = {A critical review on Glaucoma and its management in Ayurveda},
journal = {International journal of Indian medicine},
year = {2022},
doi = {10.55552/ijim.2022.3402}
}
EUVIMED